Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-03-15

著者

• MITANI Kinuko

  Department of Hematology, Dokkyo University School of Medicine

• YAMAGATA Tetsuya

  Department of Polymer Science and Engineering,Faculty of Textile Science,Kyoto Institute of Technolo

• OHYASHIKI Kazuma

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• Eguchi Mariko

  Department of Internal Medicine, Kitasato University School of Medicine

• Eguchi Mariko

  獨協医科大学 医学部血液内科学

• Eguchi Mariko

  Department Of Hematology Dokkyo Medical University School Of Medicine

• EGUCHI ISHIMAE

  Department of Hematology, Dokkyo Medical University School of Medicine

• Ohyashiki Kazuma

  First Department Of Internal Medicine Tokyo Medical University

• Miyazawa Keisuke

  Department Of Hematology Tokyo Medical University

• Ohyashiki Kazuma

  First Deparmtne Of Internal Medicine Tokyo Medical University

• Yamagata Tetsuya

  Department Of Hematology Dokkyo Medical University School Of Medicine

• Eguchi Mariko

  Department Of Cancer Cytogenetics Division Of Molecular Biology Research Institute For Radiation Bio

• Eguchi Ishimae

  Department Of Hematology Dokkyo Medical University School Of Medicine

• Maki Kazuhiro

  Department Of Hematology Dokkyo University School Of Medicine

• Mitani Kinuko

  Department Of Hematology Dokkyo Medical University

• MITANI Kinuko

  Department of Hematology and Oncology, Dokkyo Medical University School of Medicine

• OHYASHIKI Kazuma

  First Department of Internal Medicine, Tokyo Medical University

• Yamagata Tetsuya

  Department of Geriatric Dentistry, Showa University, School of Dentistry

関連論文

• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
• Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
• Endobronchial Minute Leiomyoma in a Patient with Malignant Lymphoma
• Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
• Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
• Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
• Role of the RUNX1-EVI1 fusion gene in leukemogenesis
• RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein α function
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• An Interpretation for the First- and Second-Order Phase Transitions in Nylon 66 Crystal Based on the Intra- and Intermolecular Energy Calculation
• Energetically Stable Conformations of Nylon 66 and Nylon 6 Molecules in Crystals
• Visceral Obesity in Japanese Patients with Metabolic Syndrome : Reappraisal of Diagnostic Criteria by CT Scan
• Persistent Insulin-Sensitizing Effects of Sarpogrelate Hydrochloride, a Serotonin 2A Receptor Antagonist, in Patients With Peripheral Arterial Disease
• A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
• Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
• Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
• Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
• High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
• Bepridil Was More Effective Than Class I Antiarrhythmic Drugs toPrevent the Atrial Fibrillation in "Hybrid-Therapy" of Atrial Flutter-Fibrillation
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Mutation Analysis of the WT1 Gene in Myelodysplastic Syndromes
• Frameshift Mutations of the hMSH6 Gene in Human Leukemia Cell Lines
• c-Cbl Is Inducibly Tyrosine-phosphorylated by Epidermal Growth Factor Stimulation in Fibroblasts, and Constitutively Tyrosine-phosphorylated and Associated with v-Src in v-src-transformed Fibroblasts
• Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
• A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
• Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
• Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
• A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
• Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
• Facilitated Method of Mixing Tissue Conditioner to Minimize the Formation of Air Bubbles
• Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
• Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
• Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
• Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• Disparity Between the Macroglobulin-Producing Components of 2 Cases of Follicular Lymphoma With Waldenstrom's Macroglobulinemia
• Homeobox genes in hematopoiesis and leukemogenesis
• Myeloid/Natural Killer Cell Precursor Acute Leukemia Accompanied by Homozygous Protein C Deficiency
• Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
• Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
• IgA-λ/IgG-к Biclonal Myeloma in which Two Clones Proliferated in Individual Sites
• A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
• Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
• Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
• Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
• Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
• Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
• Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
• Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
• CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
• Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
• The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
• Leukemia-related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis
• In Vitro Cleavage of the MLL Gene by Topoisomerase II Inhibitor (Etoposide) in Normal Cord and Peripheral Blood Mononuclear Cells
• OJ-350 Qantitative Assessment of Right Ventricular Structural Abnormalities in Right Ventricle-originated Tachycardia and Brugada Syndrome by Right Ventricular Myocardial Scintigraphy(Arrhythmia, diagnosis/pathophysiology/EPS-4 (A) OJ59,Oral Presentation
• Simultaneous Evaluations of Visceral-fat and Abdominal Aortic Calcification by Multi-slice X-ray Computed Tomography for Metabolic Syndrome in Japanese (X-ray/CT/MRI/DSA 8 (I), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Limitations of spontaneous reperfusion and conventional medical therapy to afford myocardial protection through antecedent angina pectoris in acute myocardial infarction
• Molecular Pathogenesis of MLL-Associated Leukemias
• The Role of the MLL Gene in Infant Leukemia
• Protein Expression of Cell Cycle Regulator, p27^, Correlates with Histopathological Grade of Non-Hodgkin's Lymphoma
• Instability of chromosome 7 in colony forming cells of patients with aplastic anemia
• Fluorescence in situ Hybridization Analysis of 12;21 Translocation in Japanese Childhood Acute Lymphoblastic Leukemia
• Detection of Residual Host Cells in Sex-mismatched Bone Marrow Transplantation in Various Hematological Diseases by Fluorescence in situ Hybridization
• The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
• Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
• Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol
• Trisomy 11 Acute Myeloid Leukemia: 5 Additional Cases From the Japan Adult Leukemia Study Group AML-92 and AML-95 Databases
• Treatment outcome of infant leukemia in Japan
• Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens
• Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera
• Low-Level Expression of ETV6/TEL in Patients with Myelodysplastic Syndrome
• TEL/ETV6 Binds to Corepressor KAP1 via the HLH Domain
• Runx1/AML1 in Normal and Abnormal Hematopoiesis
• Low Frequency of BCL10 Gene Mutations in B-Cell Non-Hodgkin's Lymphoma
• Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome
• Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
• Myelodysplastic Syndrome Accompanied by Addison's Disease and Multiple Autoimmune Phenomena: Steroid Therapy Resolved Cytopenias and All Immune Disorders
• Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
• Brain Abscess in Acute Myeloid Leukemia
• Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2^* magnetic resonance
• A Long-Survival Case of Systemic AL Amyloidosis with Nephrotic Syndrome
• Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
• Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
• Chromosomal abnormalities and oncogenes
• An Adult Case of Acute Disseminated Encephalomyelitis Accompanied with Measles Infection
• The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
• Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
• Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
• 5q-syndrome in Japan
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
• Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
• Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
• Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
• An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
• Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera
• Fadd and Skp2 are possible downstream targets of RUNX1-EVI1

もっと見る 閉じる

スポンサーリンク